Cargando…
Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study
The Global Antimicrobial Resistance Surveillance System (GLASS) is one of the pillars of the global action plan on antimicrobial resistance launched by the World Health Organization in 2015. This study was conducted to determine the feasibility and benefits of GLASS as a component of antimicrobial s...
Autores principales: | Sirijatuphat, Rujipas, Chayangsu, Sunee, Srisompong, Jintana, Ruangkriengsin, Darat, Thamlikitkul, Visanu, Tiengrim, Surapee, Wangchinda, Walaiporn, Koomanachai, Pornpan, Rattanaumpawan, Pinyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944575/ https://www.ncbi.nlm.nih.gov/pubmed/35326811 http://dx.doi.org/10.3390/antibiotics11030348 |
Ejemplares similares
-
Impact of Antibiotic Authorisation at Three Provincial Hospitals in Thailand: Results from a Quasi-Experimental Study
por: Wangchinda, Walaiporn, et al.
Publicado: (2022) -
Implementation of Clinical Practice Guidelines for Empirical Antibiotic Therapy of Bacteremia, Urinary Tract Infection, and Pneumonia: A Multi-Center Quasi-Experimental Study
por: Koomanachai, Pornpan, et al.
Publicado: (2022) -
Development and Implementation of a Mobile Application for Choosing Empirical Antimicrobial Therapy for Bacteremia, Pneumonia, Urinary Tract Infection, and Skin and Soft Tissue Infection among Hospitalized Patients
por: Chaloernpoj, Kanthon, et al.
Publicado: (2023) -
Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study
por: Sirijatuphat, Rujipas, et al.
Publicado: (2022) -
Safety and Efficacy of Ivermectin for the Prevention and Treatment of COVID-19: A Double-Blinded Randomized Placebo-Controlled Study
por: Angkasekwinai, Nasikarn, et al.
Publicado: (2022)